Remove Ads

Share on Facebook Share on Twitter

Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Sorting Out Bronchitis Symptoms
#1
Rainbow 
[size=4][b]Bronchitis Symptoms - Sorting Out Bronchitis Symptoms[/b][/size][hr]Bronchitis symptoms will most commonly begin to be manifest following a bout of the flu or the common cold. The body cannot manage to heal itself fully, and symptoms such as heavy coughing will begin to be manifest, this coughing could be dry, or phlegmy. The cough produced by bronchitis can potentially last for several weeks, also bringing with it the possibility of pain in the chest and abdomen, as well as difficulty breathing to the point of wheezing.

You have been suffering with bronchitis symptoms for longer than two weeks or have had a fever for even just a couple of days, you may need to call your physician's office for an appointment. You need to rule out pneumonia. Also, if you start coughing up blood or have phlegm with a rusty tint, you need to be checked immediately. If a virus has caused the bronchitis, your physician will not be able to do much to treat the bronchitis. The doctor can treat you with medications for relief of the symptoms associated with bronchitis. However, only time and rest will help the bronchitis, itself. At any cost, do not accept a prescription for antibiotics. They may affect your immune system's ability to attack the disease and eradicate it. Also, they will not help your bronchitis. It is always better to have compositions with as little corrections in it as possible. This is why we have written this composition on Bronchitis Symptoms with no corrections for the reader to be more interested in reading it.

[list][*]Advil, Tylenol, and aspirin are three of the most often used medications to treat bronchitis symptoms.[*]However, aspirin is not advised for anyone eighteen years old or younger.[*]A complication known as Reye's Syndrome can occur which could be fatal.[*]Drinking a lot of liquids can help to avoid the dehydration normally associated with fever.[*]It can also relieve an irritated throat from constant coughing.[*]Another treatment for the cough is over the counter cough suppressants.[*]The presentation of an article on Treat Bronchitis plays an important role in getting the reader interested in reading it.[*]This is the reason for this presentation, which has gotten you interested in reading it! [/list]

The fluoroquinolones are a relatively new group of antibiotics. Fluoroquinolones were first introduced in 1986, but they are really modified quinolones, a class of antibiotics, whose accidental discovery occurred in the early 1960.

[size=large][b]Conditions Treated With Fluoroquinolones: Indications and Uses[/b][/size][hr]The newer fluoroquinolones have a wider clinical use and a broader spectrum of antibacterial activity including gram-positive and gram-negative aerobic and anaerobic organisms. Some of the newer fluoroquinolones have an important role in the treatment of community-acquired pneumonia and intra-abdominal infections. The serum elimination half-life of the fluoroquinolones range from 3 -20 hours, allowing for once or twice daily dosing. Producing such an interesting anecdote on Bronchitis took a lot of time and hard work. So it would be enhancing to us to learn that you have made good use of this hard work!

[size=large][b]Third Generation[/b][/size][hr]The third-generation fluoroquinolones are separated into a third class because of their expanded activity against gram-positive organisms, particularly penicillin-sensitive and penicillin-resistant S. pneumoniae, and atypical pathogens such as Mycoplasma pneumoniae and Chlamydia pneumoniae. Although the third-generation agents retain broad gram-negative coverage, they are less active than ciprofloxacin against Pseudomonas species. We can proudly say that there is no competition to the meaning of Bronchitis, when comparing this article with other articles on Bronchitis found on the net.

[size=large][b]Second Generation[/b][/size][hr]The second-generation fluoroquinolones have increased gram-negative activity, as well as some gram-positive and atypical pathogen coverage. Compared with first-generation quinolones, these drugs have broader clinical applications in the treatment of complicated urinary tract infections and pyelonephritis, sexually transmitted diseases, selected pneumonias and skin infections. The development of Chronic Bronchitis has been explained in detail in this article on Chronic Bronchitis. Read it to find something interesting and surprising!

Because of their expanded antimicrobial spectrum, third-generation fluoroquinolones are useful in the treatment of community-acquired pneumonia, acute sinusitis and acute exacerbations of chronic bronchitis, which are their primary FDA-labeled indications. The third-generation fluoroquinolones include levofloxacin, gatifloxacin, moxifloxacin and sparfloxacin. We do not mean to show some implication that Bronchitis have to rule the world or something like that. We only mean to let you know the actual meaning of Bronchitis!

The fluoroquinolones are a family of synthetic, broad-spectrum antibacterial agents with bactericidal activity. The parent of the group is nalidixic acid, discovered in 1962 by Lescher and colleagues. The first fluoroquinolones were widely used because they were the only orally administered agents available for the treatment of serious infections caused by gram-negative organisms, including Pseudomonas species.

[b]Because of concern about hepatotoxicity, trovafloxacin therapy should be reserved for life- or limb-threatening infections requiring inpatient treatment (hospital or long-term care facility), and the drug should be taken for no longer than 14 days.[/b]

All of the fluoroquinolones are effective in treating urinary tract infections caused by susceptible organisms. They are the first-line treatment of acute uncomplicated cystitis in patients who cannot tolerate sulfonamides or TMP, who live in geographic areas with known resistance > 10% to 20% to TMP-SMX, or who have risk factors for such resistance. The facts on Chronic Bronchitis mentioned here have a consequential impact on your understanding on Chronic Bronchitis. This is because these facts are the basic and important points about Chronic Bronchitis.

[i]Fluoroquinolones advantages: Ease of administration Daily or twice daily dosing Excellent oral absorption Excellent tissue penetration Prolonged half-lives Significant entry into phagocytic cells Efficacy Overall safety[/i]

The newer fluoroquinolones have a wider clinical use and a broader spectrum of antibacterial activity including gram-positive and gram-negative aerobic and anaerobic organisms. Some of the newer fluoroquinolones have an important role in the treatment of community-acquired pneumonia and intra-bronchial infection lungs. The first impression is the best impression. We have written this article on Bronchitis in such a way that the first impression you get will definitely make you want to read more about it!

[size=large][b]Classification of Fluoroquinolones[/b][/size][hr]As a group, the fluoroquinolones have excellent in vitro activity against a wide range of both gram-positive and gram-negative bacteria. The newest fluoroquinolones have enhanced activity against gram-positive bacteria with only a minimal decrease in activity against gram-negative bacteria. Their expanded gram-positive activity is especially important because it includes significant activity against Streptococcus pneumoniae.

[size=large][b]Fourth Generation[/b][/size][hr]The fourth-generation fluoroquinolones add significant antimicrobial activity against anaerobes while maintaining the gram-positive and gram-negative activity of the third-generation drugs. They also retain activity against Pseudomonas species comparable to that of ciprofloxacin. The fourth-generation fluoroquinolones include trovafloxacin (Trovan). We have included the history of Bronchitis here so that you will learn more about its history. It is only through it's history can you learn more about Bronchitis.

Second-generation agents include ciprofloxacin, enoxacin, lomefloxacin, norfloxacin and ofloxacin. Ciprofloxacin is the most potent fluoroquinolone against P. aeruginosa. Ciprofloxacin and ofloxacin are the most widely used second-generation quinolones because of their availability in oral and intravenous formulations and their broad set of FDA-labeled indications. We are proud to say we have dominance in the say of Chronic Bronchitis. This is because we have read vastly and extensively on Chronic Bronchitis.

Urinary tract infections (norfloxacin, lomefloxacin, enoxacin, ofloxacin, ciprofloxacin, levofloxacin, gatifloxacin, trovafloxacin) Lower respiratory tract infections (lomefloxacin, ofloxacin, ciprofloxacin, trovafloxacin) Skin and skin-structure infections (ofloxacin, ciprofloxacin, levofloxacin, trovafloxacin) Urethral and cervical gonococcal infections (norfloxacin, enoxacin, ofloxacin, ciprofloxacin, gatifloxacin, trovafloxacin) Prostatitis (norfloxacin, ofloxacin, trovafloxacin) Acute sinusitis (ciprofloxacin, levofloxacin, gatifloxacin, moxifloxacin (Avelox), trovafloxacin) Acute exacerbations of chronic bronchitis (levofloxacin, sparfloxacin (Zagam), gatifloxacin, moxifloxacin, trovafloxacin) Community-acquired pneumonia (levofloxacin, sparfloxacin, gatifloxacin, moxifloxacin, trovafloxacin) Don't be surprised if you find anything unusual here about Chronic Bronchitis. There has been some interesting and unusual things here worth reading.

[size=large][b]Fluoroquinolones Disadvantages:[/b][/size][hr]Tendonitis or tendon rupture Multiple drug interactions Not used in children Newer quinolones produce additional toxicities to the heart that were not found with the older agents Having a penchant for Bronchitis led us to write all that there has been written on Bronchitis here. Hope you too develop a penchant for Bronchitis!

[size=large][b]First Generation[/b][/size][hr]The first-generation agents include cinoxacin and nalidixic acid, which are the oldest and least often used quinolones. These drugs had poor systemic distribution and limited activity and were used primarily for gram-negative urinary tract infections. Cinoxacin and nalidixic acid require more frequent dosing than the newer quinolones, and they are more susceptible to the development of bacterial resistance. There has been an uncalculatable amount of information added in this composition on Bronchitis. Don't try counting it!
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)